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Objectives The purpose of this study was to quantify the effects of coronary atherosclerosis morphology and extent on
myocardial flow reserve (MFR).
Background Although the relationship between coronary stenosis and myocardial perfusion is well established, little is known
about the contribution of other anatomic descriptors of atherosclerosis burden to this relationship.
Methods We evaluated the relationship between atherosclerosis plaque burden, morphology, and composition and re-
gional MFR (MFRregional) in 73 consecutive patients undergoing Rubidium-82 positron emission tomography and
coronary computed tomography angiography for the evaluation of known or suspected coronary artery disease.
Results Atherosclerosis was seen in 51 of 73 patients and in 107 of 209 assessable coronary arteries. On a per-vessel
basis, the percentage diameter stenosis (p  0.02) or summed stenosis score (p  0.002), integrating stenoses
in series, was the best predictor of MFRregional. Importantly, MFRregional varied widely within each coronary steno-
sis category, even in vessels with nonobstructive plaques (n  169), 38% of which had abnormal MFRregional (2.0).
Total plaque length, composition, and remodeling index were not associated with lower MFR. On a per-patient
basis, the modified Duke CAD (coronary artery disease) index (p  0.04) and the number of segments with
mixed plaque (p  0.01) were the best predictors of low MFRglobal.
Conclusions Computed tomography angiography descriptors of atherosclerosis had only a modest effect on downstream
MFR. On a per-patient basis, the extent and severity of atherosclerosis as assessed by the modified Duke CAD
index and the number of coronary segments with mixed plaque were associated with decreased MFR. (J Am
Coll Cardiol 2011;58:1807–16) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.06.051In patients with coronary artery disease (CAD), manage-
ment decisions are generally based on the severity of
symptoms and the magnitude of inducible myocardial ischemia.
Although the anatomic severity of epicardial coronary ste-
nosis has been used as a surrogate of functional significance,
there is increased recognition that there is great individual
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accepted June 14, 2011.variability and that complementary hemodynamic evalua-
tion can improve the identification of patients who will
benefit from revascularization (1). Coronary computed to-
mography angiography (CTA) offers accurate, rapid, and
noninvasive delineations of the extent and severity of ana-
tomic CAD. Single- and multicenter studies have demon-
strated that coronary CTA has high sensitivity and negative
predictive value for excluding significant CAD (2). Recent
See page 1817
studies have shown that predictions of flow-limiting disease
based on the severity of stenosis identified by CTA have the
same limitations as those identified for conventional coro-
nary angiography (3,4). Unlike conventional coronary an-
giography, CTA allows detailed delineation of other aspects
of atherosclerosis beyond the severity of luminal narrowing,
including plaque morphology and vessel remodeling. How-
c
n
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the relationship between these
integrated anatomic descriptors
of disease severity and coronary
hemodynamics. Our objective
was to evaluate the relationship
between plaque extent, severity,
and morphology by CTA and
with functional downstream ef-
fect on myocardial perfusion as
defined by estimates of myocar-
dial blood flow (MBF) (in ml/
min/g) and flow reserve derived
by positron emission tomography
(PET).
Methods
Study population. Seventy-three consecutive patients with
suspected or known stable CAD referred for coronary CTA
and rubidium-82 myocardial perfusion PET imaging within
a 14-day interval were included in this analysis. Patients
with previous coronary artery bypass grafting were excluded,
as were those with valvular heart disease or a left ventricular
ejection fraction40%. For each subject, information about
their medical history, coronary risk factors, and medication
use was collected at the time of their imaging study.
The study was approved by the Partners Healthcare
Institutional Review Board, and all study procedures were in
accordance with institutional guidelines.
Hybrid PET and CTA study. PET SCAN. Patients were
studied using a whole-body PET computed tomography (CT)
scanner (Discovery RX or STE LightSpeed 64, GE Health-
care, Milwaukee, Wisconsin) after an overnight fast. Patients
were instructed to avoid caffeine and methylxanthine-
containing substances for 24 h.
MBF was measured at rest and during peak hyperemia
using rubidium-82 as a perfusion tracer, as described pre-
viously (5). Briefly, after transmission imaging and begin-
ning with the intravenous bolus administration of
rubidium-82 (1,480 to 2,220 MBq), list mode images were
acquired for 7 min. Then, intravenous dipyridamole (0.142
mg/kg/min for 4 min; n  14), adenosine (0.142 mg/kg/
min for 4 min; n  53), or (0.4-mg bolus; n  6) was
infused. At peak hyperemia, a second dose of rubidium-82
was injected, and images were recorded in the same manner.
The heart rate, systemic blood pressure, and 12-lead elec-
trocardiogram were recorded at baseline and every minute
during and after the infusion of the vasodilator. The rate
pressure product was calculated by multiplying heart rate
and systolic blood pressure measured at rest and during peak
hyperemia, respectively.
CTA SCAN. Coronary CTA was performed using a 64-
hannel CT scanner (GE Discovery VCT, GE Healthcare;
 68) or 320-channel CT scanner (Aquilion One,
Abbreviations
and Acronyms
CAD  coronary artery
disease
CT  computed
tomography
CTA  computed
tomography angiography
MBF  myocardial blood
flow
MFR  myocardial flow
reserve
PET  positron emission
tomographyToshiba America Medical Systems, Tustin, California; n  s5). Patients with a heart rate60 beats/min received 5 to 15
mg metoprolol intravenously immediately before the CT
scan. All patients with a systolic blood pressure 90 mm
Hg before administration of contrast received 0.4 mg of
sublingual nitroglycerin. The mean heart rate during CTA
was 62  8 beats/min.
A low-dose scout scan was performed to define ana-
tomic landmarks for the contrast-enhanced study. Before
each scan, a test bolus of 10 to 20 ml of Ultravist 370
(370 mg/ml of iodine) was injected at 5 ml/s. The timing of
peak contrast enhancement in the ascending aorta was then
used to determine the timing of scan acquisition. The
contrast-enhanced scan used 60 to 90 ml of Ultravist 370
intravenously (rate, 5 ml/s) during a single breath-hold
(10 s).
CTA data were acquired using the following parameters
for studies performed with GE Discovery VCT: collima-
tion, 0.625 mm; gantry rotation, 300 ms; helical acquisition
using a pitch of 0.16, tube current, 300 to 600 mA with
ECG tube current modulation; tube voltage, 120 kV;
rotation time, 0.35 s, and for studies performed with
Aquilion One: collimation, 0.50 mm; gantry rotation, 350
ms; axial volume acquisition using prospective electrocar-
diographic triggering, x-ray tube current, 300 to 550 mA;
x-ray tube voltage, 120 kV. Retrospective electrocardiogra-
phy gating was used to reconstruct images at mid-diastole
(65% to 75%, in 5% increments) for patients with low heart
rates (65 beats/min), and in end-systole (45% to 60%, in
5% increments) for patients with higher heart rates (65
beats/min). The cardiac phase with the best image quality
was used for analysis.
Data analysis. QUANTIFICATION OF MBF. List mode im-
ages were unlisted and then reconstructed into 27 frames as
described previously (5). To compute a semiquantitative
summed stress score and a summed difference score, a
standard 17-segment, 5-point scoring system was used.
Commercially available software was used to calculate rest
and stress left ventricular ejection fraction (Corridor 4DM,
Ann Arbor, Michigan). To measure absolute MBF value,
right and left ventricular blood pool time-activity curves
were obtained using factor analysis (5). Regional and global
rest and peak MBFs were then calculated by fitting the
rubidium-82 time–activity curves with a 2-compartment
tracer kinetic model and modeled extraction fraction as
described previously (5,6). Regional (MFRregional) and
global MFR (MFRglobal) were computed as the ratio of peak
MBF to rest MBF. Regional coronary vascular resistance
was computed as the ratio of mean arterial blood pressure to
MBF. This methodology was validated against 13N-
ammonia as the reference standard at our institution. In
addition, the reproducibility of the MBF estimates in
repeated rubidium-82 studies was very good, both at rest
and during peak stress (R2  0.935), and no absolute
ystematic error was observed (5,6).
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GRAPHIC INFORMATION. Standard PET/CTA fusion soft-
ware (HeartFusion, GE Healthcare) was used to facilitate
ascertainment of the exact correspondence between the
territorial region of interest used to estimate the MFRregional
and the location of coronary stenoses (Fig. 1). Each of the
17 PET myocardial segments was assigned to the corre-
Figure 1 Rubidium-82 PET/CTA Fusion Imaging and Correlation
Integrated positron emission tomography/computed tomography angiography (PET
(A) Curved multiplanar reconstructions. The proximal left anterior descending arte
(LCx) artery shows calcified plaques with 47% stenosis proximally and 77% stenos
nosis. The summed stenosis score was 19 in the LAD, 6 in the LCx, and 16 in th
shows extensive and severe ischemia in LAD territory with transit ischemic dilation
were supplied by a large-dominant LCx in contrast to the standard American Heart
1.05 in the LAD, LCx, and RCA territories, respectively. The MFRglobal was 1.28. Dsponding coronary vessel by 2 expert readers. MFRregionalwas computed based on these assignments by averaging
MBF reserve values involving all segments distal to the most
severe angiographic stenosis, regardless of whether a perfu-
sion defect was present. For vessels without any stenosis, all
segments subtended by the vessel were averaged.
QUANTIFICATION OF ATHEROSCLEROTIC BURDEN. Re-
constructed CTA images were analyzed on a dedicated
ween Regional MFR and Coronary Stenoses
study in a 66-year-old man with obesity, dyslipidemia, and diabetes mellitus.
) shows a long calcified plaque with 85% stenosis. The left circumflex artery
ally. The right coronary arter (RCA) has a proximal calcified plaque with 92% ste-
The Duke CAD index was 74. (B) Stress and rest myocardial perfusion imaging
PET/CTA fusion imaging demonstrating that the mid- and basal inferior segments
iation model. (D) Regional myocardial flow reserve (MFR) was 0.57, 1.72, and
 distal left anterior descending artery.Bet
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eter of 1.5 mm were using a 17-segment model. Ten
vessels were excluded due to motion artifact or previous
stent implantation and/or myocardial infarction, leaving a
total of 209 coronary vessels for the per-vessel analysis. For
the evaluation of plaque morphology and severity, thin
multiplanar reformation was used to view both cross-
sectional and longitudinal images.
Definitions of descriptors of atherosclerotic burden.
Plaque length was measured as the distance (in millimeters)
from the proximal to the distal shoulder of each plaque.
Total plaque length was calculated for each coronary vessel
and for each patient globally by summing the lengths of
individual plaques along each coronary vessel and in each
patient. Epicardial luminal narrowing was assessed by quan-
tifying the percentage diameter stenosis. The percentage of
diameter stenosis was calculated by dividing the minimal
lumen diameter of each stenosis by the proximal normal
artery diameter. To account for serial plaques within each
vessel, each coronary segment was graded using a 5-point
scoring system (0 no plaque, 1 1% to 24% stenosis, 2
25% to 49%, 3  50% to 69%, 4  70% to 100%). From
these segmental scores, a summed stenosis score was then
derived by adding individual segmental scores for each
vessel and each patient.
Plaque composition was assessed by measuring the
Hounsfield units within each plaque. Plaques with a CT
density 150 Hounsfield units were considered calcified.
Noncalcified plaque showed only a noncalcified component.
Mixed plaque had both calcified and noncalcified components.
The remodeling index was calculated as the ratio of the
overall vessel diameter at the site of maximal stenosis to that
of a neighboring proximal nonstenotic segment, and vessels
were subgrouped as follows: an index 1.10 identified
vessels with negative remodeling and no remodeling; an
index 1.10 to 1.29 defined mild to moderate positive
remodeling, whereas an index 1.30 defined extensive
positive remodeling. The most severely stenotic plaque in
each coronary vessel was identified as the index lesion for
the per-vessel analysis.
Finally, a modified Duke CAD index integrating the
number of affected vessels and the location of disease with
50% stenosis was used to quantify the extent and severity
of CAD on a per-patient level (7).
Statistical analysis. Continuous variables were presented
as mean  SD or median and quartile, and categorical
variables were as simple proportions. To correct for right-
ward skew, MFR and MBF data were logarithmically
transformed before further analysis. For per-patient analy-
ses, univariate regression was used to explore the association
among MFRglobal and demographic variables, coronary risk
actors, and CTA descriptors. A multivariate regression
odel was used to identify independent predictors of
FRglobal among significant univariate variables. To exam-ne the correlation between quantitative MFRglobal andsemiquantitative summed stress score and summed differ-
ence score, Pearson’s correlation coefficient was used.
For the per-vessel analysis, diameter stenosis was catego-
rized as no disease, 1% to 49%, 50% to 69%, and 70%
stenosis. Differences in rest MBFregional, peak MBFregional,
and MFRregional across these categories were evaluated for
ignificance with analysis of variance of the log-transformed
alues. To account for confounding due to the inclusion of
ultiple vessels per patient (i.e., clustering), a mixed-effects
odel was used for regression analysis with per-patient
andom effect to account for intrapatient correlation.
ixed-effects models were used to evaluate the relationship
etween MFRregional and the percentage of diameter steno-
is or summed stenosis score and to explore the role of
dditional CTA descriptors as well as traditional coronary
isk factors.
Receiver-operator characteristic curves were constructed
or the identification of patients with the modified Duke
AD index 50 (i.e., those with 2-vessel disease with
roximal left anterior descending artery involvement or
-vessel disease) using MFRglobal. A 2-tailed p value 0.05
as considered statistically significant.
esults
atient characteristics. Baseline characteristics of the pa-
ients studied are summarized in Table 1. The population
as sex balanced. Thirty-one of 73 patients had a body mass
Patient Characteristics (n  73)Table 1 Patient Characteristics (n  73)
Demographics
Age, yrs 60.6 12.0
Male 33 (45)
BMI, kg/m2 30.8 8.1
BMI 30 kg/m2 31 (42)
Previous myocardial infarction 6 (8)
CAD risk factors
Hypertension 45 (62)
Diabetes 14 (19)
Dyslipidemia 44 (60)
Tobacco use 4 (5)
Family history 27 (37)
CAD risk factors
None 8 (11)
1 65 (89)
2 42 (56)
3 22 (30)
Medications
Antihypertensive medications 45 (62)
ACE inhibitor or ARB 21 (29)
Beta-blocker 35 (48)
Calcium-channel blocker 15 (21)
Statin 42 (58)
Aspirin 38 (52)
Values are mean  SD or n (%).
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; BMI  body mass
index; CAD  coronary artery disease.
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each present in 60% of the patients, whereas diabetes was
present in nearly 20%. The use of medications for control of
blood pressure and cholesterol was widespread. The fre-
quency of coronary risk factors was very high, with 89% of
subjects having 1 or more coronary risk factors, 56% having
2 or more, and nearly one-third having 3 or more.
CTA FindingsTable 2 CTA Findings
Patient characteristics (n  73)
Vessels involved
No atherosclerosis 22 (30)
Nonobstructive disease 27 (37)
1-vessel disease 9 (12)
2-vessel disease 8 (11)
3-vessel disease 7 (10)
Modified Duke CAD index 15.7 25.3
Summed stenosis score 6.4 8.5
Total plaque length, mm 40.0 57.2
No. (%) of segments
With any plaque 2.9 3.1
With calcified plaque 2.4 2.7
With noncalcified plaque 0.2 0.5
With mixed plaque 0.4 0.9
With positive remodeling 1.5 1.8
1 (0–3)*
Vessel characteristics (n  209)
Stenosis severity
No plaque 102 (49)
1%–24% 24 (11)
25%–49% 43 (21)
50%–69% 18 (9)
70% 22 (10)
Summed stenosis score 2.4 3.4
No. of segments with plaque 1.1 1.3
Total plaque length, mm 14.4 24.8
Plaque composition
Predominantly calcified 80 (75)
Noncalcified 10 (9)
Mixed 17 (16)
Positive vascular remodeling index
1.10 48 (45)
1.10–1.29 51 (48)
1.30 8 (7)
Values are n (%) or mean  SD. *Median (interquartile range).
CAD  coronary artery disease; CTA  computed tomographic angiography.
Regional Myocardial Perfusion and Percentage of Diameter StenosTable 3 Regional Myocardial Perfusion and Percentage of Diam
0% (No Plaque) 1%
Quantitative myocardial perfusion
Rest MBF, ml/g/min 1.01 (0.81–1.21) 0.93 (0
Peak MBF, ml/g/min 2.19 (1.54–3.76) 1.83 (1
MFR 2.33 (1.73–2.91) 2.12 (1Values are median (interquartile range). *Significant variables by the analysis of variance of the log-trans
MBF  myocardial blood flow; MFR  myocardial flow reserve; other abbreviations as in Table 2.Atherosclerosis burden and regional myocardial perfusion:
per-vessel analysis. Of the 209 vessels analyzed, 107 (51%)
had evidence of atherosclerotic plaque. Among these, 18
vessels had 50% to 69% stenosis and 22 had 70% stenosis.
Three-fourths of the vessels had predominantly calcified
lesions. The average plaque length was approximately 15
mm, although the range was quite broad (interquartile
range: 0 to 19.6 mm) (Table 2).
Rest MBFregional was comparable across the entire spec-
trum of stenosis severity (Table 3). In contrast, there was a
stepwise decrease in both peak MBFregional and MFRregional
with increasing stenosis severity (Table 3, Figs. 2 and 3).
Among normal coronary vessels by CTA, MFRregional was
igher in patients without coronary risk factors or remote
isease than that in patients with coronary risk factors or
emote disease (p  0.038). In subgroup analysis of angio-
raphically normal coronary vessels, no significant associa-
ions were found between MFRregional and patient demo-
graphics, coronary risk factors, or the presence of remote
disease. Of note, MFRregional varied widely within each
coronary stenosis category, even in vessels with nonobstruc-
tive CAD (Fig. 2).
Table 4 describes the results of multivariable analyses
exploring the associations between estimates of coronary
hemodynamics (MFRregional, peak MBFregional, and coro-
ary vascular resistanceregional) and patient demographics,
oronary risk factors, and anatomic data using 2 models that
ncluded the percentage of diameter stenosis (model 1) or
ummed stenosis score (model 2). Overall, both models
ere highly significant using any of the 3 descriptors of
oronary artery physiology. Interestingly, the presence of
bstructive disease in any vessel (50%) was associated with
ecreased MFRregional in remote vessels without apparent
obstructive disease. However, other CTA-derived descrip-
tors of epicardial coronary atherosclerosis (i.e., total plaque
length, plaque composition, and remodeling index) were not
significantly associated with reduced MFRregional.
Quantitative relationship between the extent of CAD
and myocardial perfusion: per-patient analysis. CTA-
derived descriptors of coronary atherosclerosis on a patient
level are summarized in Table 2. More than two-thirds of
patients had either normal coronary arteries or only nonob-
structive disease. Multivessel obstructive CAD (2- and
3-vessel disease) was present in 21% of patients.
Stenosis
% Diameter Stenosis by CTA
50%–69% >70% p Value
21) 1.27 (0.98–1.47) 1.03 (0.87–1.34) 0.10
14) 2.07 (1.54–3.53) 1.69 (1.23–1.98) 0.03*
68) 1.66 (1.45–2.07) 1.78 (1.13–2.19) 0.001*iseter
–49%
.75–1.
.40–3.
.75–2.formed values.
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Atherosclerotic Burden and Coronary Flow Reserve October 18, 2011:1807–16By semiquantitative visual analysis of PET images, 42
patients had normal scans (summed stress score  0), 11
had a summed stress score of 1 to 3, and 20 patients had a
summed stress score 4. Quantitative MFRglobal was in-
versely correlated with the semiquantitative summed stress
score (r  0.34, p  0.01) and summed difference score
(r  0.31, p  0.01). As in the per-vessel analysis,
FRglobal and peak MBFglobal showed a modest inverse
orrelation with the severity of CAD, as defined by the
odified Duke CAD index (Fig. 4).
Interestingly, 17 of 42 patients (40%) with normal PET
erfusion imaging on qualitative analysis had quantitative
FRglobal 2.0. Five of these 17 patients (29%) had
significant obstructive CAD (50% stenosis) by CTA. In
contrast, only 2 of 25 patients (8%) with a normal scan and
preserved MFR (MFRglobal2.0) showed obstructive CAD
y CTA. Quantitative MFRglobal improved the identifica-
tion of patients with high-risk coronary anatomy by CTA
(Duke CAD index 50) including those with 2-vessel
CAD with proximal left anterior descending artery stenosis
50% and 3-vessel CAD (Fig. 5). This was true even
among patients with normal findings on PET (summed
stress score  zero) or relatively low-risk findings on PET
scans (summed stress score 3) by semiquantitative visual
analysis. An MFRglobal 2.0 had a sensitivity of 0.91 (95%
onfidence interval: 0.59 to 1.00) and specificity of
.58 (95% confidence interval: 0.45 to 0.70) to identify
igh-risk CAD by CTA. Similar values were obtained for
he normal and relatively low-risk subgroups (receiver-
perator characteristic area  0.93 and 0.89, respectively)
Figure 2 Per-Vessel Relationship Between MFR and
Percentage of Diameter Stenosis Categories
Scatterplots and box and whiskers plots demonstrating the distributions of
regional myocardial reserve (MFRregional) in vessels with no plaque (patients
with no risk factors [RF] or remote disease; patients with 1 RF or remote dis-
ease), 1% to 49%, 50% to 69%, and 70% diameter stenosis, respectively.
Although there is a significant relationship between stenosis severity and
MFRregional, there is wide variability. CTA  computed tomography angiography;
PET  positron emission tomography.(Fig. 5).In multivariable analyses including demographic data,
coronary risk factors, and CTA data, only the modified
Duke CAD index (standardized coefficient  0.380, p 
0.04) and the number of coronary segments with mixed
plaque (standardized coefficient  0.585, p  0.01) were
significantly associated with reduced MFRglobal (Table 5).
iscussion
here are several important findings in this study. First, on
per-vessel basis, we found a statistically significant but
linically modest relationship between the degree of stenosis
everity by CTA and its downstream effect of coronary
rtery physiology as assessed by MFR, peak MBF, or
oronary vascular resistance. Second, there appears to be
idespread physiologic variability in peak MBF and MFR
ven in coronary territories supplied by angiographically
ormal vessels or those with nonobstructive disease. Third,
lobal quantitative estimates of MFR were sensitive markers
Figure 3
Per-Vessel Relationship Between
MFR and Percentage of Diameter
Stenosis or Summed Stenosis Score
Scatterplots demonstrating the inverse relationship between the percentage
of diameter stenosis and MFRregional (A), and summed stenosis score and
MFRregional (B). Solid lines indicate the best fit lines from a multivariate
mixed model with 95% confidence intervals for the mean indicated by the
dashed lines. CI  confidence interval; other abbreviations as in Figure 2.
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October 18, 2011:1807–16 Atherosclerotic Burden and Coronary Flow ReserveMultivariable Models Describing Associations Between CTA Descriptors of Atherosclerosis Burden and MBF, MFR, and CVRTable 4 Multivariable Models Describing Associations Between CTA Descriptors of Atherosclerosis Burden and MBF, MFR, and CVR
Variable
MFR Peak MBF Peak CVR
Standardized Coefficient p Value Standardized Coefficient p Value Standardized Coefficient p Value
Model 1: Demographics, CAD Risk Factors, Percentage of Stenosis, and Other CTA Descriptors of Atherosclerosis
2 Log-likelihood 98.5 0.001 89.3 0.001 78.8 0.001
Demographics
Age, yrs 0.154 0.20 0.279 0.02* 0.370 0.001*
Male 0.084 0.48 0.142 0.22 0.232 0.04*
BMI, kg/m2 0.078 0.53 0.171 0.18 0.148 0.22
Previous MI 0.075 0.72 0.419 0.04* 0.375 0.05
CAD risk factors
Hypertension 0.075 0.53 0.051 0.67 0.141 0.22
Diabetes 0.114 0.47 0.146 0.35 0.091 0.54
Dyslipidemia 0.002 0.98 0.056 0.63 0.037 0.74
Tobacco use 0.134 0.59 0.360 0.15 0.604 0.02*
Family history 0.006 0.96 0.029 0.81 0.017 0.88
CTA findings
% diameter stenosis 0.233 0.02* 0.133 0.04* 0.118 0.06
Vessel (LAD, LCx, RCA) N/A 0.39 N/A 0.006* N/A 0.003*
Total plaque length, mm 0.043 0.48 0.018 0.63 0.024 0.51
Plaque composition 0.37 0.82 0.86
Calcified 0.065 0.68 0.061 0.55 0.065 0.52
Noncalcified 0.109 0.59 0.122 0.34 0.100 0.43
Mixed 0.275 0.17 0.055 0.67 0.042 0.74
Remodeling index 0.80 0.94 0.87
1.10 0.530 0.37 0.141 0.71 0.081 0.83
1.10–1.29 0.064 0.59 0.035 0.64 0.057 0.44
1.30 0.011 0.95 0.021 0.86 0.021 0.86
Remote lesion 50% 0.181 0.04* 0.022 0.73 0.0004 0.99
Model 2: Demographics, CAD Risk Factors, Summed Stenosis Score, and Other CTA Descriptors of Atherosclerosis
2 Log-likelihood 90.0 0.001 76.4 0.001 66.0 0.001
Demographics
Age, yrs 0.152 0.20 0.269 0.02* 0.358 0.002*
Male 0.064 0.58 0.117 0.31 0.206 0.06
BMI, kg/m2 0.078 0.53 0.177 0.16 0.155 0.19
Previous MI 0.104 0.61 0.440 0.03* 0.394 0.04*
CAD risk factors
Hypertension 0.060 0.61 0.055 0.64 0.143 0.21
Diabetes 0.100 0.53 0.127 0.42 0.072 0.63
Dyslipidemia 0.002 0.99 0.047 0.68 0.029 0.80
Tobacco use 0.120 0.63 0.361 0.15 0.599 0.03*
Family history 0.001 0.99 0.026 0.83 0.020 0.86
CTA findings
Summed stenosis score 0.298 0.002* 0.223 0.0003* 0.210 0.0005*
Vessel (LAD, LCx, RCA) N/A 0.23 N/A 0.01* N/A 0.006*
Total plaque length, mm 0.132 0.06 0.092 0.04* 0.094 0.03*
Plaque composition 0.08 0.70 0.71
Calcified 0.064 0.68 0.060 0.55 0.063 0.51
Noncalcified 0.075 0.70 0.107 0.39 0.088 0.47
Mixed 0.408 0.03* 0.024 0.84 0.028 0.81
Remodeling index 0.79 0.91 0.85
1.10 0.592 0.31 0.093 0.80 0.034 0.92
1.10–1.29 0.056 0.62 0.031 0.67 0.051 0.45
1.30 0.064 0.74 0.070 0.56 0.068 0.56
Remote lesion 50% 0.174 0.04* 0.038 0.53 0.018 0.77
*Statistically significant variables.
CVR coronary vascular resistance; LAD left anterior descending coronary artery; LCx left circumflex coronary artery; MImyocardial infarction; N/A not applicable; RCA right coronary artery;
other abbreviations as in Tables 1 to 3.
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disease by CTA.
There is growing and consistent evidence supporting the
high sensitivity and negative predictive value of CTA for
ruling out the presence of obstructive CAD (2,3). However,
the presence of coronary plaques on CTA is more problem-
atic to interpret clinically because the technique offers only
moderate accuracy to delineate the stenosis severity com-
pared with quantitative coronary angiography. An addi-
tional problem is that estimates of anatomic severity of
CAD by CTA or conventional angiography are only modest
predictors of downstream ischemia (8). Unlike conventional
angiography, CTA allows a more detailed assessment of
plaque burden including plaque morphology and composi-
tion as well as vessel remodeling. It has been hypothesized
Figure 4 Per-Patient Relationship
Between MFR and Duke CAD Index
Scatterplot showing the inverse relationship between modified Duke CAD (coro-
nary artery disease) index and MFRglobal (A) or peak MBFglobal (B). The solid
line corresponds to the best fit line with ln(MFRglobal) (A) and ln(peak MBFglobal)
(B) as the response variable and modified Duke CAD index as the predictor
variable. Dashed lines indicate the 95% mean confidence interval. MBF  myo-
cardial blood flow; other abbreviations as in Figure 2.that integration of these comprehensive anatomic descrip-tors of disease severity may improve the ability of CTA to
diagnose flow-limiting disease and, thus, help identify
patients for revascularization. Accordingly, we sought to
determine the relationships between the anatomic severity
of disease as demonstrated by CTA and its physiologic
severity as defined by quantitative estimates of MBF and
MFR as defined by PET. The use of quantitative myocar-
dial perfusion as a more sensitive means to define functional
significance builds on previous work using less sensitive
semiquantitative assessments of ischemia (9).
On a per-vessel basis, we found a statistically significant
but clinically modest relationship between the degree of
stenosis severity by CTA and MFR. Indeed, we observed
wide physiologic variability within each category of stenosis
Figure 5 Receiver-Operator Characteristic Curves for
Identification of High-Risk Coronary Anatomy
Receiver-operator characteristic curves for the identification of Duke CAD index
50 (including 2-vessel CAD with proximal LAD stenosis 50% and 3-vessel
CAD) using MFRglobal among all patients studied as well as subsets with nor-
mal (summed stress score [SSS]  0) or relatively low-risk (SSS 3) PET myo-
cardial perfusion images (MPI). Abbreviations as in Figures 1, 2, and 4.
Multivariable Predictors of MFRglobal Model:ignificant Univariate Predictorsmong Demogr phics, CAD RF , and CTA Findings
Table 5
Multivariabl Predict rs of MFRglobal Model:
Significant Univariate Predictors
Among Demographics, CAD RFs, and CTA Findings
Variable Standardized Coefficient p Value
Demographics
Age, yrs 0.147 0.22
CTA findings
Modified Duke CAD index 0.380 0.04*
Summed stenosis score 0.088 0.85
Total plaque length, mm 0.189 0.52
No. of segments
With any plaque 1.270 0.07
With mixed plaque 0.585 0.01*
With calcified plaque 1.141 0.07
2Adjusted R  0.19, p  0.004. *Statistically significant variables.
RFs  risk factors; other abbreviations as in Tables 1 to 3.
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investigators (10). Importantly, this variability between
epicardial CAD and its downstream physiologic conse-
quence is not unique to CTA and has been previously noted
with conventional quantitative coronary angiography (8,11).
These results extend those of previous studies by demon-
strating that the observations derived from conventional
coronary angiography also apply to CTA and highlights the
notion that the percentage of diameter stenosis is only a
modest descriptor of coronary resistance, confirming the
universality of these relationships using different methodol-
ogies for assessing the anatomic severity of CAD. Impor-
tantly, we found that other CTA-based descriptors of
coronary atherosclerosis unique to CTA did not add incre-
mental information beyond the quantitative percentage of
diameter stenosis for predicting decreased MFR as a down-
stream measure of impaired tissue perfusion. If these CTA
descriptors were shown to provide incremental prognostic
data over myocardial perfusion, they could be used to
identify individuals who would benefit from more aggressive
medical therapies. This needs to be examined in a larger
study. However, on a per-patient basis, the extent of
atherosclerosis as assessed by the modified Duke CAD
index (integrating the site and severity of coronary stenosis)
and the number of coronary segments with mixed plaque
were associated with decreased MFR. This finding agrees
with that reported by Lin et al. (12) and may reflect a link
between noncalcified plaques as a surrogate marker of more
diffuse coronary microvascular dysfunction.
A second observation of our study was that there appears
to be widespread physiologic variability in peak MBF and
MFR, even in coronary territories supplied by angiographi-
cally normal vessels or those with nonobstructive disease.
Interestingly, we observed that the presence of obstructive
disease (50%) in 1 vessel was associated with a decreased
MFR in remote myocardial regions supplied by vessels
without obstructive CAD. This is consistent with a small
previous study demonstrating an association between mild
atherosclerosis and impaired endothelium-dependent coro-
nary vasodilation (13). This is likely related to the adverse
effects of coronary risk factors on vascular function (14) and
its related effect on diffuse atherosclerosis, which has been
shown to affect coronary artery physiology (15–17). The
observed variability in MBF highlights the high sensitivity
of these functional estimates to factors other than upstream
epicardial stenosis (i.e., coronary risk factors, diffuse CAD,
and microvascular dysfunction). This suggests that quanti-
tative flow estimates are a sensitive but potentially not
specific marker for obstructive epicardial CAD. In fact, our
preliminary data in the per-patient–based analysis support
this notion. The precise impact of this issue on subsequent
referral for cardiac catheterization needs to be evaluated
prospectively in a larger cohort. However, this observation
may have potentially important prognostic implications
beyond diagnosis, especially for those with diabetes and
chronic kidney disease (18,19).A third observation was that global quantitative estimates
of MFR were sensitive markers for the identification of
patients with high-risk anatomic disease by CTA, especially
among patients with normal or low-risk myocardial perfu-
sion scans on semiquantitative visual analysis, which is
consistent with the increased sensitivity of MFR for detec-
tion of multivessel CAD (20,21). Although these consistent
results are encouraging, they should be viewed as hypothesis
generating because all these studies, including ours, are
small. Larger studies with angiographic confirmation are
warranted to evaluate the added value of quantitative flow
measurements for the noninvasive diagnosis of CAD.
Study limitations. Our study consisted of an entirely
physician referral–based, stable diagnostic population with
an intermediate likelihood of CAD. As such, this study
design and the nature of patients referred to stress imaging
limit the generalizability of our results to other populations
such as those with acute coronary syndromes. Larger pro-
spective studies investigating the relationship between MFR
and coronary atherosclerosis could help confirm or extend
our findings. Catheter-based coronary angiography or in-
travascular ultrasound was not performed routinely in our
patients, many of whom had normal PET scans on semi-
quantitative visual analysis. Quantitative MFR is currently
not a routine component of our clinical assessments and
reporting. However, previous studies have documented the
value of CTA for assessing plaque morphology and vessel
remodeling, as demonstrated by intravascular ultrasound.
Conclusions
There is a modest association between the severity of
stenosis quantified by CTA and its associated impairment of
downstream MFR. On a per-vessel analysis, other CTA-
based descriptors of coronary atherosclerosis did not add
incremental information beyond the quantitative percentage
of diameter stenosis for predicting decreased MFR as a
downstream measure of impaired tissue perfusion. How-
ever, on a per-patient basis, the extent of atherosclerosis as
assessed by the modified Duke CAD index (integrating the
site and severity of coronary stenosis) and the number of
coronary segments with mixed plaque were associated with
decreased MFR. The latter may reflect a link between
noncalcified plaques as a surrogate marker of more diffuse
coronary microvascular dysfunction.
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